Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate.
Girardi P, Del Casale A, Rapinesi C, Kotzalidis GD, Splendori F, Verzura C, Trovini G, Sorice S, Carrus D, Mancinelli I, Comparelli A, De Filippis S, Francomano A, Ballerini A, Marcellusi A, Mennini FS, Ducci G, Sani G, Pompili M, Brugnoli R. Girardi P, et al. Among authors: rapinesi c. Hum Psychopharmacol. 2018 May;33(3):e2658. doi: 10.1002/hup.2658. Epub 2018 May 15. Hum Psychopharmacol. 2018. PMID: 29766576
Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
Brugnoli R, Rapinesi C, Kotzalidis GD, Marcellusi A, Mennini FS, De Filippis S, Carrus D, Ballerini A, Francomano A, Ducci G, Del Casale A, Girardi P. Brugnoli R, et al. Among authors: rapinesi c. Riv Psichiatr. 2016 Mar-Apr;51(2):47-59. doi: 10.1708/2246.24194. Riv Psichiatr. 2016. PMID: 27183509 Review.
Are 5-HT3 antagonists effective in obsessive-compulsive disorder? A systematic review of literature.
Serata D, Kotzalidis GD, Rapinesi C, Janiri D, Di Pietro S, Callovini G, Piacentino D, Gasperoni C, Brugnoli R, Ferri VR, Girardi N, Tatarelli R, Ferracuti S, Angeletti G, Girardi P, Del Casale A. Serata D, et al. Among authors: rapinesi c. Hum Psychopharmacol. 2015 Mar;30(2):70-84. doi: 10.1002/hup.2461. Epub 2015 Feb 10. Hum Psychopharmacol. 2015. PMID: 25676060 Review.
Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
Del Casale A, Kotzalidis GD, Sacco M, Rapinesi C, De Giorgi R, Giardini M, D'Andreagiovanni M, Carlino N, Brugnoli R, Girardi P. Del Casale A, et al. Among authors: rapinesi c. Psychiatr Danub. 2016 Mar;28(1):91-4. Psychiatr Danub. 2016. PMID: 26938829 Free article. No abstract available.
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M. Del Casale A, et al. Among authors: rapinesi c. Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017. Curr Neuropharmacol. 2019. PMID: 30101713 Free PMC article. Review.
Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
Del Casale A, Kotzalidis GD, Rapinesi C, Girardi P. Del Casale A, et al. Among authors: rapinesi c. Curr Neuropharmacol. 2019;17(8):668-671. doi: 10.2174/1570159X1708190709144820. Curr Neuropharmacol. 2019. PMID: 31393238 Free PMC article. No abstract available.
71 results